3101 related articles for article (PubMed ID: 7573354)
21. Over-expression of apoptosis-related proteins contributes to muscular damage in the obstructed ureter of the rat.
Chuang YH; Chuang WL; Huang SP; Huang CH
BJU Int; 2002 Jan; 89(1):106-12. PubMed ID: 11849174
[TBL] [Abstract][Full Text] [Related]
22. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G
Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.
Usuki J; Horiba K; Chu SC; Moss J; Ferrans VJ
Arch Pathol Lab Med; 1998 Oct; 122(10):895-902. PubMed ID: 9786350
[TBL] [Abstract][Full Text] [Related]
24. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A
Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455
[TBL] [Abstract][Full Text] [Related]
25. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
[TBL] [Abstract][Full Text] [Related]
27. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
Al-Jamal RT; Kivelä T
Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
[TBL] [Abstract][Full Text] [Related]
28. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
29. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.
Lipponen PK
J Pathol; 1995 Feb; 175(2):203-10. PubMed ID: 7738716
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
33. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
34. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis.
King LA; Okagaki T; Gallup DG; Twiggs LB; Messing MJ; Carson LF
Gynecol Oncol; 1996 May; 61(2):227-32. PubMed ID: 8626138
[TBL] [Abstract][Full Text] [Related]
35. Expression of bcl-2 in uveal malignant melanoma.
Jay V; Yi Q; Hunter WS; Zielenska M
Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
[TBL] [Abstract][Full Text] [Related]
36. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma.
Demır D; Yaman B; Anacak Y; Keçecı B; Kandıloğlu G; Akalin T
Turk Patoloji Derg; 2014; 30(1):55-65. PubMed ID: 24448706
[TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
39. Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma.
Miracco C; Santopietro R; Biagioli M; Lazzi S; Nyongo A; Vatti R; Luzi P
J Cutan Pathol; 1998 May; 25(5):244-51. PubMed ID: 9696289
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of c-myc oncogene expression in uveal melanoma.
Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
